期刊
JOURNAL OF SMALL ANIMAL PRACTICE
卷 57, 期 11, 页码 589-599出版社
WILEY
DOI: 10.1111/jsap.12588
关键词
-
资金
- Melbourne International Research Scholarship (MIRS)
- Melbourne International Fee Remission (MIFR)
The aim of this review is to discuss why chronic enteropathy might be a better term than inflammatory bowel disease in dogs, because the treatment and outcome of the disease is very different from that of inflammatory bowel disease in humans. The effect of food, antibiotics and immunosuppressant drugs on chronic enteropathy will be reviewed. New treatments under investigation will also be introduced. Although there are several studies evaluating treatment of chronic enteropathy in dogs, the quality and quantity of evidence supporting individual therapies remains scarce and more work is needed to improve management of this disease. Finally, new findings about dogs with chronic enteropathy complicated by protein-losing enteropathy will be discussed. Although prognosis for these dogs is poor, recent data might help improve their treatment.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据